Cancer clinical trials in the region Bourgogne-Franche-Comté

205 currently recruiting clinical trials
Region Bourgogne-Franche-Comté

Phase 1 / Phase 2 Liver and bile duct cancer #NCT06188702 #2025-521249-25-00
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma Locally Advanced Metastatic MTAP 1 2 3 or more
Systemic Treatment-Naive
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Servier
Phase 1 / Phase 2 Pancreas cancer #NCT06188702 #2025-521249-25-00
Adenocarcinoma Locally Advanced Metastatic MTAP 1 2 3 or more
Systemic Treatment-Naive
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Servier
Phase 1 / Phase 2 Lung cancer #NCT06188702 #2025-521249-25-00
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC Non-squamous NSCLC Locally Advanced Metastatic MTAP 1 2 3 or more
Systemic Treatment-Naive
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Servier
Phase 1 / Phase 2 Breast cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Bladder / Urinary Tract / Urethral cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT06188702 #2025-521249-25-00
Locally Advanced Metastatic MTAP 1 2 3 or more
Systemic Treatment-Naive
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Servier
Phase 1 / Phase 2 Stomach and esophageal cancer #NCT02735057 #2024-514998-21-00
Esophagus Adenocarcinoma Squamous cell carcinoma Locally Advanced None Systemic Treatment-Naive
Centre Hospitalier Universitaire de Besançon (Besançon)
Centre Hospitalier Universitaire de Besancon
Phase 1 / Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT05706129 #2023-504254-35-00
Urothelial carcinoma Locally Advanced Metastatic 1 2 3 or more Immunotherapy Chemotherapy Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Debiopharm International SA
Phase 1 / Phase 2 Colon cancer Rectal cancer #NCT05706129 #2023-504254-35-00
Locally Advanced Metastatic 1 2 3 or more Chemotherapy Targeted therapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Debiopharm International SA
Phase 1 / Phase 2 Kidney cancer #NCT05706129 #2023-504254-35-00
Other Localized None Systemic Treatment-Naive
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Debiopharm International SA
Phase 1 / Phase 2 Kidney cancer #NCT05706129 #2023-504254-35-00
Clear cell carcinoma Locally Advanced Metastatic 2 3 or more Targeted therapy Immunotherapy Targeted therapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Debiopharm International SA
Phase 1 / Phase 2 Pancreas cancer #NCT05706129 #2023-504254-35-00
Adenocarcinoma Locally Advanced Metastatic 1 2 3 or more Chemotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Debiopharm International SA